Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17345248 | 0.88 | HPGD (0.46) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL17349886 | 0.87 | HPGD (0.45) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL17345234 | 0.86 | HPGD (0.47) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL17051377 | 0.84 | MAPT (0.42) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL17055367 | 0.83 | MAPT (0.41) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL14562384 | 0.83 | ALDH1A1 (0.61) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL17637037 | 0.81 | KMT2A (0.61) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL16489905 | 0.81 | BCHE (0.40) | MEN1KMT2AALDH1A1MGLLBCHE | |
| SCHEMBL13383361 | 0.79 | ALDH1A1 (0.62) | HPGDMEN1KMT2ATP53MAPT | |
| SCHEMBL16489885 | 0.79 | ALDH1A1 (0.65) | HPGDMEN1KMT2ATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | ESD, ELL, ASH2L | HPGD 2578/4885MEN1 2780/4885KMT2A 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.